The molecular weight of Sch 36606 (2) is established as 535 on the basis of FAB mass spectral data. A protonated molecular ion, M+H+, m/z 536 was observed. The major 1 TLC performed on polyamide sheets developing with 1.5% aq formic acid. fragment ion m/z 435 represents the cleavage of cytosine from 2, and thus follows the same fragmentation pattern observed for 1 and other related nucleoside antibiotics5). The UV data for 2 are as follows:^max (H2O, pH 7) nm (s) 269 (8,000) and (0.01 n HC1) nm (s) 276 (ll,000). Acidic hydrolysis of 2 (2 n HC1, reflux 2 hours) gave cytosine and leucine that were identified with the authentic samples. The 13C NMRdata for 2 are given in Table 1 . The data are consistent with the structure of 2 and establish the identity as leucylblasticidin S. The configurations of amino acids and of the pyran-3-ene ring were determined as follows. Acid hydrolysis of 1 and 2 (6n HC1, 105°C, 17 hours) and blasticidin S (3)f yields blastidic acid6) and leucine, together with other hydrolysis products. The aminoacids were separated and purified by passing the acid hydrolysate through by Kaken Pharmaceutical Co., Ltd., Japan. shown in Table 2 . Previous reports show that blastidic acid obtained from blasticidin S was assigned the L-configuration by comparative ORD studies6). On the basis of our rotation measurements of blastidic acids obtained from 1, 2 and 3, these acids are identical and are as- We examined the absolute configuration of the pyran-3-ene ring indicated in Fig. 1 CD spectra for 1, 2 and 3 are shown in Fig. 2 . They all show a negative cotton effect with thê max close to 270 nm. The absolute configuration of blasticidin S was previously reported as possessing a pyran-3-ene ring in the /3-d form6). Since the signs of the cotton effect are identical for all three compounds (and the amino acids have the same L-configuration) it is reasonable to assume the /3-d form for the pyran-3-ene ring 
